Efficacy endpoints: Month 3 of SWABIMS compared to the end of SWABIMS Extension Study (month 27) (FAS, N = 27).

N: number of patients with data; SD: standard deviation; EDSS: Expanded Disability Status Scale; MSFC: Multiple Sclerosis functional Composite; ¶ Treatment differences were calculated using ANCOVA.N：纳入完整数据的患者例数（number of patients with data）；SD：标准差（standard deviation）；EDSS：扩展残疾状态量表（Expanded Disability Status Scale）；MSFC：多发性硬化功能综合评分（Multiple Sclerosis functional Composite）；组间治疗差异采用协方差分析（ANCOVA）计算。